InvestorsHub Logo
Followers 4
Posts 372
Boards Moderated 0
Alias Born 08/13/2019

Re: rafunrafun post# 213273

Monday, 09/09/2019 12:52:56 PM

Monday, September 09, 2019 12:52:56 PM

Post# of 425892

MRC on Twitter yesterday:
Quote:
We decided to [short Amarin] because very few purchased the report. And we think greater compensation is suitable for the work put in. It’s a dependent compensation this way—if our report is quality and we are right, we will be well compensated when the CRL and patent litigation loss comes.


Narrator: IRS are rooting for you.



Speaking of patent litigation, replies to the dockets filed on 30 Aug 2019 are due on Thursday:

https://www.pacermonitor.com/public/case/19726810/Amarin_Pharma_Inc_et_al_v_WestWard_Pharmaceuticals_Corp_et_al
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News